This work highlights the capacity of Flt3L-driven DCs to regulate alloreactive CD4+ T-cell responses in a way that is highly advantageous for GvHD and may preserve GvL by sparing alloreactive CD8+ T-cells. Here, FLT3LG is linked to graft versus host disease.